Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Mariacarmela Santarpia, Elisa Giovannetti, Christian Rolfo, Niki Karachaliou, Maria González-Cao, Giuseppe Altavilla & Rafael Rosell. (2016) Recent developments in the use of immunotherapy in non-small cell lung cancer. Expert Review of Respiratory Medicine 10:7, pages 781-798.
Read now
Read now
Mariano R. Gabri, Walter Cacciavillano, Guillermo L. Chantada & Daniel F. Alonso. (2016) Racotumomab for treating lung cancer and pediatric refractory malignancies. Expert Opinion on Biological Therapy 16:4, pages 573-578.
Read now
Read now
Ana María Hernández & Ana María Vázquez. (2015) Racotumomab–alum vaccine for the treatment of non-small-cell lung cancer. Expert Review of Vaccines 14:1, pages 9-20.
Read now
Read now
Christian Rolfo, Giovanni Sortino, Evelien Smits, Francesco Passiglia, Giuseppe Bronte, Marta Castiglia, Antonio Russo, Edgardo S Santos, Annelies Janssens, Patrick Pauwels & Luis Raez. (2014) Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?. Expert Review of Anticancer Therapy 14:10, pages 1173-1187.
Read now
Read now
John Nemunaitis. (2013) Cancer targeting vaccines: Surrogate measures of activity. Human Vaccines & Immunotherapeutics 9:1, pages 213-218.
Read now
Read now
Yuniel Fernández-Marrero & Alejandro López-Requena. (2011) Lonely killers. mAbs 3:6, pages 528-534.
Read now
Read now
Antonio Rossi, Paolo Maione, Clorinda Schettino, Maria Anna Bareschino, Paola Claudia Sacco, Rita Ambrosio, Valentina Barbato, Rosario Zeppa, Giovanni Palazzolo & Cesare Gridelli. (2011) Non-small-cell lung carcinoma vaccines in clinical trials. Expert Review of Vaccines 10:6, pages 887-897.
Read now
Read now
Olivia Simmons, Mitchell Magee & John Nemunaitis. (2010) Current vaccine updates for lung cancer. Expert Review of Vaccines 9:3, pages 323-335.
Read now
Read now
Articles from other publishers (45)
Eddie Grimmett, Bayan Al-Share, Mohamad Basem Alkassab, Ryan Weng Zhou, Advait Desai, Mir Munir A. Rahim & Indryas Woldie. (2022) Cancer vaccines: past, present and future; a review article. Discover Oncology 13:1.
Crossref
Crossref
Miguel García-Pardo, Teresa Gorria, Ines Malenica, Stéphanie Corgnac, Cristina Teixidó & Laura Mezquita. (2022) Vaccine Therapy in Non-Small Cell Lung Cancer. Vaccines 10:5, pages 740.
Crossref
Crossref
Andrea De Giglio, Alessandro Di Federico, Giacomo Nuvola, Chiara Deiana & Francesco Gelsomino. (2021) The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines). Current Oncology Reports 23:11.
Crossref
Crossref
Jasmine Kaur, Jackson Elms, Alan L. Munn, David Good & Ming Q. Wei. (2021) Immunotherapy for non-small cell lung cancer (NSCLC), as a stand-alone and in combination therapy. Critical Reviews in Oncology/Hematology 164, pages 103417.
Crossref
Crossref
Paola Giussani, Alessandro Prinetti & Cristina Tringali. (2021) The Role of Sphingolipids in Cancer Immunotherapy. International Journal of Molecular Sciences 22:12, pages 6492.
Crossref
Crossref
Shing Yi Pan, Yvonne Cashinn Chia, Hui Rong Yee, Angelina Ying Fang Cheng, Clarice Evey Anjum, Yenny Kenisi, Mike KS Chan & Michelle BF Wong. (2021) Immunomodulatory potential of anti-idiotypic antibodies for the treatment of autoimmune diseases. Future Science OA 7:2.
Crossref
Crossref
Julie R. Brahmer, Melissa L. Johnson, Manuel Cobo, Santiago Viteri, Juan Coves Sarto, Ammar Sukari, Mark M. Awad, Ravi Salgia, Vali A. Papadimitrakopoulou, Arun Rajan, Nibedita Bandyopadhyay, Alicia J. Allred, Mark Wade, Gary E. Mason, Enrique Zudaire, Roland E. Knoblauch, Nicole Stone, Matthew V. Lorenzi & Raffit Hassan. (2021) JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes–Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies. JTO Clinical and Research Reports 2:2, pages 100103.
Crossref
Crossref
Shawn J. Rice, Victoria Hyland, Madhusmita Behera, Suresh S. Ramalingam, Paul Bunn & Chandra P. Belani. (2020) Guidance on the Clinical Management of Electronic Cigarette or Vaping-Associated Lung Injury. Journal of Thoracic Oncology 15:11, pages 1727-1737.
Crossref
Crossref
Necdet Uskent, Sule Ayla, Nil Molinas Mandel, Metin Ozkan, Mehmet Teomete, Huseyin Baloglu, Cenk Aydıncer, Hale Yergok, Ender Dogan, Barkın Berk & Aziz Yazar. (2020) Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy. Journal of Oncology 2020, pages 1-7.
Crossref
Crossref
Valeria I. Segatori, Héctor A. Cuello, Cynthia A. Gulino, Marina Albertó, Cecilia Venier, Marcelo D. Guthmann, Ignacio A. Demarco, Daniel F. Alonso & Mariano R. Gabri. (2018) Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patients. Cancer Immunology, Immunotherapy 67:8, pages 1285-1296.
Crossref
Crossref
Timothy J. Vreeland, Garth S. Herbert & George E. Peoples. 2018. Immunotherapy in Translational Cancer Research. Immunotherapy in Translational Cancer Research
72
90
.
Marie Viala, Marie Vinches, Marie Alexandre, Caroline Mollevi, Anna Durigova, Nadia Hayaoui, Krisztian Homicsko, Alice Cuenant, Céline Gongora, Luca Gianni & Diego Tosi. (2018) Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection. British Journal of Cancer 118:5, pages 679-697.
Crossref
Crossref
Mayrel Labrada, Denise Dorvignit, Giselle Hevia, Nely Rodríguez-Zhurbenko, Ana M. Hernández, Ana M. Vázquez & Luis E. Fernández. (2018) GM3(Neu5Gc) ganglioside: an evolution fixed neoantigen for cancer immunotherapy. Seminars in Oncology 45:1-2, pages 41-51.
Crossref
Crossref
Wan-Ling Ho, Wen-Ming Hsu, Min-Chuan Huang, Kenji Kadomatsu & Akira Nakagawara. (2016) Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma. Journal of Hematology & Oncology 9:1.
Crossref
Crossref
M. Virginia Gentilini, M. Eugenia P?rez, Pablo Mariano Fern?ndez, Leonardo Fainboim & Elo?sa Arana. (2016) The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction. Cancer Immunology, Immunotherapy 65:5, pages 551-562.
Crossref
Crossref
Walter Cacciavillano, Claudia Sampor, Cecilia Venier, Mariano R. Gabri, María T.G. de Dávila, Maria L. Galluzzo, Marcelo D. Guthmann, Leonardo Fainboim, Daniel F. Alonso & Guillermo L. Chantada. (2015) A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory Malignancies. Pediatric Blood & Cancer 62:12, pages 2120-2124.
Crossref
Crossref
David P. Carbone, David R. Gandara, Scott J. Antonia, Christoph Zielinski & Luis Paz-Ares. (2015) Non–Small-Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy. Journal of Thoracic Oncology 10:7, pages 974-984.
Crossref
Crossref
Ana Vanesa Torbidoni, Alejandra Scursoni, Sandra Camarero, Valeria Segatori, Mariano Gabri, Daniel Alonso, Guillermo Chantada & María Teresa G. de Dávila. (2014)
Immunoreactivity of the 14F7 Mab raised against
N
‐Glycolyl
GM
3 Ganglioside in retinoblastoma tumours
. Acta Ophthalmologica 93:4.
Crossref
Crossref
Hongyan Cheng, Xue Ye, Xiaohong Chang, Ruiqiong Ma, Xu Cong, Yidong Niu, Menglei Zhang, Kai Liu, Heng Cui & Jianli Sang. (2015) Construction, expression, and function of 6B11ScFv–mIL-12, a fusion protein that attacks human ovarian carcinoma. Medical Oncology 32:4.
Crossref
Crossref
Livan Delgado-Roche. (2014) The response-to-retention hypothesis: From theory to the potential therapeutic approaches. Biomedicine & Aging Pathology 4:4, pages 291-295.
Crossref
Crossref
Sailyn Alfonso, Anet Valdés-Zayas, Eduardo R. Santiesteban, Yoanna I. Flores, Fernando Areces, Maurenis Hernández, Carmen E. Viada, Ivis C. Mendoza, Pedro P. Guerra, Elena García, Ramón A. Ortiz, Ana V. de la Torre, Meylán Cepeda, Kirenia Pérez, Eric Chong, Ana María Hernández, Darien Toledo, Zuyén González, Zaima Mazorra, Tania Crombet, Rolando Pérez, Ana María Vázquez & Amparo E. Macías. (2014) A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients. Clinical Cancer Research 20:14, pages 3660-3671.
Crossref
Crossref
Zaima Mazorra Herrera & Tania Crombet Ramos. (2014) Pilot study of a novel combination of two therapeutic vaccines in advanced non-small-cell lung cancer patients. Cancer Immunology, Immunotherapy 63:7, pages 737-747.
Crossref
Crossref
Thomas Kieber-Emmons, Somdutta Saha, Anastas Pashov, Behjatolah Monzavi-Karbassi & Ramachandran Murali. (2014) Carbohydrate-Mimetic Peptides for Pan Anti-Tumor Responses. Frontiers in Immunology 5.
Crossref
Crossref
K. de la Luz-Hernández, Y. Rabasa, R. Montesinos, D. Fuentes, J.F. Santo-Tomás, O. Morales, Y. Aguilar, B. Pacheco & A. Castillo. (2014) Cancer vaccine characterization: From bench to clinic. Vaccine 32:24, pages 2851-2858.
Crossref
Crossref
Ron Amon, Eliran Moshe Reuven, Shani Leviatan Ben-Arye & Vered Padler-Karavani. (2014) Glycans in immune recognition and response. Carbohydrate Research 389, pages 115-122.
Crossref
Crossref
Eduardo Santiesteban, Leslie Perez, Sailyn Alfonso, Elia Neninger, Soraida Acosta, Yoana Flores, Maurenis Hernandez, Carmen Viada, Robin García, Meylán Cepeda, Daymys Estevez, Yoisbel Moreno & Amparo Macías. (2014) Safety and Efficacy of Racotumomab-Alum Vaccine as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer. International Journal of Clinical Medicine 05:14, pages 844-850.
Crossref
Crossref
Sarah Declerck & Johan Vansteenkiste. (2014) Immunotherapy for lung cancer: ongoing clinical trials. Future Oncology 10:1, pages 91-105.
Crossref
Crossref
Tania Lahera, Adanays Calvo, Griselda Torres, Charles E. Rengifo, Santiago Quintero, Mar?a del Carmen Arango, Debora Danta, Jos? M. V?zquez, Xiomara Escobar & Adriana Carr. (2014) Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer. Journal of Oncology 2014, pages 1-8.
Crossref
Crossref
María Inés Penna, Marcelo D. Guthmann, María Laura Ardigó & Roberto E. Gómez. (2013) Inmunoterapia con Racotumomab. Oncología Clínica 18:2.
Crossref
Crossref
Ryuichi Morishita & Hironori NakagamiJohn Nemunaitis. 2013. Gene Therapy: Technologies & Applications. Gene Therapy: Technologies & Applications
12
33
.
Yosdel SotoEmilio AcostaLivan DelgadoArlenis PérezViviana FalcónMaría A. BécquerÁngela FragaVíctor BritoIrene ÁlvarezTania GriñánYuniel Fernández-MarreroAlejandro López-RequenaMiriam NoaEduardo FernándezAna María Vázquez. (2012) Antiatherosclerotic Effect of an Antibody That Binds to Extracellular Matrix Glycosaminoglycans. Arteriosclerosis, Thrombosis, and Vascular Biology 32:3, pages 595-604.
Crossref
Crossref
L G Durrant, P Noble & I Spendlove. (2012) Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy. Clinical and Experimental Immunology 167:2, pages 206-215.
Crossref
Crossref
L. Guilleminault, E. Lemarié & N. Heuzé-Vourc’h. (2012) Monoclonal Antibodies: An Emerging Class of Therapeutics in Non Small Cell Lung Cancer. Journal of Cancer Therapy 03:06, pages 1170-1190.
Crossref
Crossref
Jerrie Gavalchin. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Leodevico L. Ilag. (2011) Immunoglobulin M as a vaccine adjuvant. Medical Hypotheses 77:4, pages 473-478.
Crossref
Crossref
Jia-Jia Wang, Chen Luo, Yue-Hui Li & Guan-Cheng Li. (2011) Modulatory effects of tumor-derived heat shock protein in DNA vaccination against nasopharyngeal carcinoma. International Immunopharmacology 11:4, pages 462-467.
Crossref
Crossref
Ana María Hernández, Nely Rodríguez, Jorge E. González, Emma Reyes, Teresa Rondón, Tania Griñán, Amparo Macías, Sailyn Alfonso, Ana María Vázquez & Rolando Pérez. (2011) Anti-NeuGcGM3 Antibodies, Actively Elicited by Idiotypic Vaccination in Nonsmall Cell Lung Cancer Patients, Induce Tumor Cell Death by an Oncosis-Like Mechanism. The Journal of Immunology 186:6, pages 3735-3744.
Crossref
Crossref
Alejandra M. Scursoni, Laura Galluzzo, Sandra Camarero, Jessica Lopez, Fabiana Lubieniecki, Claudia Sampor, Valeria I. Segatori, Mariano R. Gabri, Daniel F. Alonso, Guillermo Chantada & María Teresa G. de Dávila. (2011) Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer. Clinical and Developmental Immunology 2011, pages 1-6.
Crossref
Crossref
Ronan J. Kelly, James L. Gulley & Giuseppe Giaccone. (2010) Targeting the Immune System in Non–Small-Cell Lung Cancer: Bridging the Gap Between Promising Concept and Therapeutic Reality. Clinical Lung Cancer 11:4, pages 228-237.
Crossref
Crossref
Alejandra M. Scursoni, Laura Galluzzo, Sandra Camarero, Norma Pozzo, Mariano R. Gabri, Cristina Mateo de Acosta, Ana María Vázquez, Daniel F. Alonso & María Teresa G. de Dávila. (2011) Detection and Characterization of N-Glycolyated Gangliosides in Wilms Tumor by Immunohistochemistry. Pediatric and Developmental Pathology 13:1, pages 18-23.
Crossref
Crossref
Luis E. Fernandez, Mariano R. Gabri, Marcelo D. Guthmann, Roberto E. Gomez, Silvia Gold, Leonardo Fainboim, Daniel E. Gomez & Daniel F. Alonso. (2010) NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines. Clinical and Developmental Immunology 2010, pages 1-8.
Crossref
Crossref
Hester van Cruijsen, Mariëlle Gallegos Ruiz, Paul van der Valk, Tanja D de Gruijl & Giuseppe Giaccone. (2009) Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer. BMC Cancer 9:1.
Crossref
Crossref
Cesare Gridelli, Antonio Rossi, Paolo Maione, Marianna Luciana Ferrara, Vincenzo Castaldo & Paola Claudia Sacco. (2009) Vaccines for the Treatment of Non-Small Cell Lung Cancer: A Renewed Anticancer Strategy. The Oncologist 14:9, pages 909-920.
Crossref
Crossref
Y. Diaz, A. Gonzalez, A. Lopez, R. Perez, A. M. Vazquez & E. Montero. (2008) Anti-ganglioside anti-idiotypic monoclonal antibody-based cancer vaccine induces apoptosis and antiangiogenic effect in a metastatic lung carcinoma. Cancer Immunology, Immunotherapy 58:7, pages 1117-1128.
Crossref
Crossref
Ana María Hernández, Darién Toledo, Darel Martínez, Tania Griñán, Victor Brito, Amparo Macías, Sailyn Alfonso, Teresa Rondón, Eduardo Suárez, Ana María Vázquez & Rolando Pérez. (2008) Characterization of the Antibody Response against NeuGcGM3 Ganglioside Elicited in Non-Small Cell Lung Cancer Patients Immunized with an Anti-Idiotype Antibody. The Journal of Immunology 181:9, pages 6625-6634.
Crossref
Crossref